Cmax and AUC0-14 reticulocyte counts by dose group
. | Dose group . | . | . | . | . | . | |||
---|---|---|---|---|---|---|---|---|---|
. | Placebo . | 0.025 mg/kg . | 0.05 mg/kg . | 0.1 mg/kg . | F test* . | P . | |||
No. subjects | 8 | 4 | 5 | 10 | NA | NA | |||
Mean Cmax, 109/L, ± SD | 61 ± 16 | 148 ± 39 | 186 ± 44 | 227 ± 41 | 34.2 | < .001 | |||
Mean AUC0-14, 109/L × d, ± SD | 661 ± 205 | 1390 ± 439 | 1502 ± 273 | 1932 ± 416 | 20.3 | < .001 |
. | Dose group . | . | . | . | . | . | |||
---|---|---|---|---|---|---|---|---|---|
. | Placebo . | 0.025 mg/kg . | 0.05 mg/kg . | 0.1 mg/kg . | F test* . | P . | |||
No. subjects | 8 | 4 | 5 | 10 | NA | NA | |||
Mean Cmax, 109/L, ± SD | 61 ± 16 | 148 ± 39 | 186 ± 44 | 227 ± 41 | 34.2 | < .001 | |||
Mean AUC0-14, 109/L × d, ± SD | 661 ± 205 | 1390 ± 439 | 1502 ± 273 | 1932 ± 416 | 20.3 | < .001 |
NA indicates not applicable.
One-way ANOVA.